Stock Research: Fleury

Peer-based, data-driven stock research by Obermatt enables quick and easy due diligence for your stock investing.

What's New

Recent improvements to enhance your investment research experience

360° View free for everyone

Our most comprehensive analysis—the 360° View—is now free for everyone. To maintain our research quality, other ranks are now part of our new subscription plans.

3 new subscription models

Plans for every investor - from stock ideas to in-depth analysis.

Similar Stocks

Four stock alternatives to the stock you're searching.

Fleury

BOVESPA:FLRY3 BRFLRYACNOR5
30
  • Value
    37
  • Growth
    28
  • Safety
    Safety
    94
  • Combined
    63
  • Sentiment
    16
  • 360° View
    360° View
    30
Unlock
Which ranks are driving this 360° View?
Subscribe to View
Company Description

Fleury SA is a Brazil-based medical laboratory services company. It operates in patient service centers (private medical diagnostics), B2B (clinical analysis and diagnostic imaging for partners), and dental diagnosis. Popular brands include Fleury Medicina e Saude, Clinica Felippe Mattoso e Weinmann, a+ Medicina Diagnostica, Diagnoson a+, Diagmax, and Inlab. The company primarily operates throughout Brazil. In the last fiscal year, the company had 22900 employees, a market cap of $1268 million, profits of $347 million, and revenue of $1244 million.

more
Analysis

ANALYSIS: With an Obermatt 360° View of 30 (better than 30% compared with alternatives), overall professional sentiment and financial characteristics for the stock Fleury are below the industry average. The 360° View is based on consolidating four consolidated indicators, with three out of four indicators below average for Fleury. Only the consolidated Value Rank has an attractive rank of 94, which means that the share price of Fleury is on the lower side compared with the typical size in indicators such as revenues, profits, and invested capital. This means that the stock price is lower than for 94% of alternative stocks in the same industry. All other consolidated ranks are below average. The consolidated Growth Rank has a low rank of 28, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. The consolidated Safety Rank has a riskier rank of 37, meaning the company has a riskier financing structure than 63% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, professionals are more pessimistic about the stock than for 84% of alternative investment opportunities, reflected in the consolidated Sentiment Rank of 16. ...read more

more
Index
BOVESPA
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 10-Sep-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
94 98 88 95
Growth
28 44 99 33
Safety
Safety
37 34 16 30
Sentiment
16 40 74 76
360° View
360° View
30 62 90 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
23 23 45 7
Opinions Change
19 15 75 83
Pro Holdings
n/a 60 30 56
Market Pulse
69 93 97 81
Sentiment
16 40 74 76
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
94 98 88 95
Growth
28 44 99 33
Safety Safety
37 34 16 30
Combined
63 79 92 57
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
85 95 84 83
Price vs. Earnings (P/E)
89 91 82 87
Price vs. Book (P/B)
81 86 73 70
Dividend Yield
92 96 85 96
Value
94 98 88 95
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
29 21 83 55
Profit Growth
25 77 87 75
Capital Growth
30 93 87 28
Stock Returns
68 18 69 11
Growth
28 44 99 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
11 13 10 6
Refinancing
89 94 64 82
Liquidity
17 17 14 25
Safety Safety
37 34 16 30

Similar Stocks

Discover high‑ranked alternatives to Fleury and broaden your portfolio horizons.

Vodacom

JSE:VOD
Country: South Africa
Industry: Wireless Telecommunication
Size: X-Large
Full Stock Analysis

Lojas Renner

BOVESPA:LREN3
Country: Brazil
Industry: Apparel Retail
Size: Medium
Full Stock Analysis

Kalbe Farma

IDX:KLBF
Country: Indonesia
Industry: Pharmaceuticals
Size: Medium
Full Stock Analysis

Localiza Rental Car

BOVESPA:RENT3
Country: Brazil
Industry: Trucking
Size: Large
Full Stock Analysis

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.